New Triple-Threat attack on lung cancer that spreads to the brain
NCT ID NCT06822543
Summary
This study is testing a combination of three drugs for people with non-small cell lung cancer that has spread to the brain and who have not yet received treatment for their advanced cancer. The goal is to see how well this three-drug combo can shrink the tumors in the brain. The trial is for patients whose cancer does not have certain genetic mutations that would make them eligible for other targeted therapies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
FUNFARME - Hospital de Base de São José do Rio Preto
RECRUITINGSão José do Rio Preto, São Paulo, 15.090-000, Brazil
Contact
Conditions
Explore the condition pages connected to this study.